Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2008-05-05
2011-11-08
Mosher, Mary E (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C530S328000, C536S023720, C536S023700, C514S020100
Reexamination Certificate
active
08053553
ABSTRACT:
Disclosed are compositions and methods for preventing or reducing harm resulting from pathogen infection. For example, disclosed are peptides that inhibit the processing of toxins normally cleaved by proprotein convertase enzymes.
REFERENCES:
patent: 2005/0089526 (2005-04-01), Moore et al.
Rodriguez-Lopez et al., Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA, 1999, Journal of General Virology, vol. 80, pp. 727-738.
Basak, et al Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides Biochem J 353:537-45 2001.
Bucci et al, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat. Med. 6:1362-1367, 2000.
Chen, et al Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation Cell 95:409-17 1998.
Chiron, et al Furin-mediated cleavage of Pseudomonas exotoxin-derived chimeric toxins. J Biol Chem 272:31707-11 1997.
Collier, et al Anthrax toxin J Annu Rev Cell Dev Biol 19:45-70, 2003.
Derossi, et al Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188-93, 1996.
Elmquist, et al VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions Exp. Cell Res. 269:237-244, 2001.
Fischer, et al, Structure activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 55:163-72, 2000.
Fogle, et al Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.J Surg Res 106:86-98, 2002.
Forino, et al Efficient synthetic inhibitors of anthrax lethal factor Proc Natl Acad Sci USA 102:9499-504, 2005.
Frankel, et al, Cellular uptake of the tat protein from human immunodeficiency virus Cell 55:1189-1193, 1988.
Fugere, et al Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains J Biol Chem 277:7648-56, 2002.
Fugere, et al Trends Pharmacol Sci Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition 26:294-301, 2005.
Gao, et al. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library Bioorg. Med. Chem. 10:4057-4065, 2002.
Green, et al, Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein Cell 55:1179-1188, 1988.
Hachmann, et al, Alternative to piperidine in Fmoc solid-phase syntheses J Comb Chem 8:149, 2006.
Hachmann, et al, Search for optimal coupling reagent in multiple peptide synthesizer Biopolymers 84:340-7, 2006.
Hong, et al. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors Cancer Res. 60:6551-6556, 2000.
Jiao, et al, Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine Pro Natl Acad Sci U S A 103:19707-12, 2006.
King, et al, A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis Int J Pept Protein Res 36:255-66, 1990.
Kozlov, et al, A method for rapid protease substrate evaluation and optimization Comb Chem High Throughput Screen 9:481-7, 2006.
Lin, et al Synthesis and properties of water-soluble core-shell-shell silica-CdSe/CdS-silica nonparticles. J Nanosci Nanotechnol 6:1092-100, 2006.
Lundberg, et al. Cell membrane translocation of the N-terminal (1-28) part of the prion proteinBiochem. Biophys. res. Commun. 299:85-90, 2002.
Morris, et al A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nature Bio. 19:1173-1176, 2001.
Oehlke, et al, Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically Biochim Biophys Acta 1414:127-139, 1998.
Park, et al, Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II Proc Natl Acad Sci USA 97:8245-8250, 2000.
Pooga, et al, Cell penetration by transportan FASEB J 12:67-77, 1998.
Remacle, et al, Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT-1-MMP. Oncogene 25:5648-55, 2006.
Rouselle et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57:679-686, 2000.
Sabet, et al, Modulation of cytokine production and enhancement of cell viability by TLR7 ligands during anthrax infection of macrophages, FEMS Immunol Med Microbiol 47:369-79, 2006.
Sawada, et al. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nature Cell Biol. 5:352-357, 2003.
Scamuffa, et al, Proprotein convertases: lessons from knockouts FASEB J 20:1954-63, 2006.
Shiryaev, et al, Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses Biochem J 401:743-52, 2007.
Stevens, et al Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus Science 303:1866-70, 2004.
Subbarao, et al Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396, 1998.
Vigneron, et al Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc. Natl. Acad. Sci. USA 93:9682-9686, 1996.
Wu, et al Immunotherapeutic activity of a novel conjugate of a toll-like receptor 7 ligand. PNAS 104:3990-3995, 2007.
Yang, et al Magnetite-containing spherical silica nanoparticles for biocatalysis and bioseparations. Anal Chem 76:1316-21, 2004. Erratum in: Anal Chem 77:354, 2005.
International Search Report and Written Opinion for PCT/US08/062654 (24520.5.9001) mailed May 5, 2009.
International Preliminary Report on Patentability for PCT/US08/062654 (24520.5.9001) mailed Dec. 7, 2009.
Day Robert
Lebl Michal
Strongin Alex
Blumel Benjamin P
Illumina, Inc.
Mosher Mary E
Pabst Patent Group LLP
Sanford-Burnham Medical Research Institute
LandOfFree
Targeting host proteinases as a therapeutic strategy against... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting host proteinases as a therapeutic strategy against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting host proteinases as a therapeutic strategy against... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4276452